Cash flow HUTCHMED (China) Limited

Equities

HCM

KYG4672N1198

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:17 06/03/2026 pm IST			5-day change	1st Jan Change
214.00 ^GBX	+5.94%		-0.47%	+2.88%

06/03	BofA Securities Adjusts HUTCHMED Price Target to $21 From $22, Maintains Buy Rating	MT
06/03	Hutchmed Limited Announces Board Changes	CI

b1967f7bdeb7340990038f52aae47cd.PrJk_0MnWDRKRA-Y4-O31g87hwrCwmJ30bsbSspG0_k.ceQhsXViKlsvAHnAjJWDlX52wUKQnQQG6OlBL_53oIFqg12WDlI9DH0MQg

Published financial data: HUTCHMED (CHINA) LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	23Cr	36Cr	43Cr	84Cr	63Cr
Total Revenues	23Cr	36Cr	43Cr	84Cr	63Cr
Cost of Goods Sold, Total	36Cr	56Cr	70Cr	69Cr	56Cr
Gross Profit	-14Cr	-20Cr	-27Cr	15Cr	6.92Cr
Selling General & Admin Expenses, Total	6.13Cr	13Cr	14Cr	13Cr	11Cr
Other Operating Expenses, Total	6.13Cr	13Cr	14Cr	13Cr	11Cr
Operating Income	-20Cr	-33Cr	-41Cr	1.84Cr	-4.37Cr
Interest Expense, Total	-8L	-6L	-7L	-8L	-28.72L
Interest And Investment Income	32.36L	20.76L	95.99L	3.61Cr	4.01Cr
Net Interest Expenses	24.49L	14.84L	89.47L	3.54Cr	3.72Cr
Income (Loss) On Equity Invest.	7.9Cr	6.06Cr	4.98Cr	4.73Cr	4.65Cr
Currency Exchange Gains (Loss)	32.65L	16.71L	-57.04L	86.61L	50.6L
Other Non Operating Income (Expenses)	12.2L	-1.19Cr	-59.72L	16.52L	51.34L
EBT, Excl. Unusual Items	-11Cr	-28Cr	-36Cr	11Cr	5.02Cr
Gain (Loss) On Sale Of Investments	-	12Cr	-	-	-
Asset Writedown	-	-	-	-57.66L	-48.04L
EBT, Incl. Unusual Items	-11Cr	-16Cr	-36Cr	11Cr	4.54Cr
Income Tax Expense	48.29L	1.19Cr	-3L	45.09L	71.92L
Earnings From Continuing Operations	-12Cr	-17Cr	-36Cr	10Cr	3.82Cr
Net Income to Company	-12Cr	-17Cr	-36Cr	10Cr	3.82Cr
Minority Interest	-1.02Cr	-2.76Cr	-4L	-3L	-4L
Net Income - (IS)	-13Cr	-19Cr	-36Cr	10Cr	3.77Cr
Net Income to Common Incl Extra Items	-13Cr	-19Cr	-36Cr	10Cr	3.77Cr
Net Income to Common Excl. Extra Items	-13Cr	-19Cr	-36Cr	10Cr	3.77Cr
Per Share Items
Net EPS - Basic	-0.18	-0.25	-0.43	0.12	0.04
Basic EPS - Continuing Operations	-0.18	-0.25	-0.43	0.12	0.04
Basic Weighted Average Shares Outstanding	70Cr	79Cr	85Cr	85Cr	86Cr
Net EPS - Diluted	-0.18	-0.25	-0.43	0.12	0.04
Diluted EPS - Continuing Operations	-0.18	-0.25	-0.43	0.12	0.04
Diluted Weighted Average Shares Outstanding	70Cr	79Cr	85Cr	87Cr	87Cr
Normalized Basic EPS	-0.11	-0.25	-0.27	0.08	0.04
Normalized Diluted EPS	-0.11	-0.25	-0.27	0.08	0.04
American Depositary Receipts Ratio (ADR)	5	5	5	5	5
Supplemental Items
EBITDA	-19Cr	-32Cr	-40Cr	2.66Cr	-3.14Cr
EBITA	-20Cr	-33Cr	-41Cr	1.84Cr	-4.37Cr
EBIT	-20Cr	-33Cr	-41Cr	1.84Cr	-4.37Cr
EBITDAR	-19Cr	-32Cr	-39Cr	3.21Cr	-2.66Cr
Total Revenues (As Reported)	23Cr	36Cr	43Cr	84Cr	63Cr
Effective Tax Rate - (Ratio)	-4.36	-7.68	0.08	4.27	15.85
Current Domestic Taxes	13.29L	1.62Cr	28.81L	18.12L	17.23L
Current Foreign Taxes	2L	4L	4L	5L	2L
Total Current Taxes	15.48L	1.66Cr	32.8L	22.83L	18.84L
Deferred Domestic Taxes	32.81L	-47.18L	-35.63L	22.26L	53.08L
Total Deferred Taxes	32.81L	-47.18L	-35.63L	22.26L	53.08L
Normalized Net Income	-7.94Cr	-20Cr	-23Cr	6.93Cr	3.09Cr
Interest on Long-Term Debt	-	6L	7L	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.13Cr	3.78Cr	4.39Cr	5.34Cr	4.86Cr
General and Administrative Expenses	5Cr	8.93Cr	9.22Cr	7.98Cr	6.43Cr
Research And Development Expense From Footnotes	18Cr	31Cr	39Cr	30Cr	21Cr
Net Rental Expense, Total	37.23L	44.12L	53.72L	55.17L	47.49L
Imputed Operating Lease Interest Expense	7L	6L	8L	6L	12.4L
Imputed Operating Lease Depreciation	30.6L	38.57L	45.23L	49.25L	35.09L
Stock-Based Comp., COGS (Total)	1.15Cr	2.58Cr	2.14Cr	2.21Cr	1.45Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	81.38L	1.62Cr	91.79L	1.45Cr	70.7L
Total Stock-Based Compensation	1.96Cr	4.2Cr	3.06Cr	3.66Cr	2.16Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	24Cr	38Cr	31Cr	28Cr	15Cr
Short Term Investments	20Cr	64Cr	32Cr	61Cr	68Cr
Total Cash And Short Term Investments	44Cr	101.45Cr	63Cr	89Cr	84Cr
Accounts Receivable, Total	4.79Cr	8.36Cr	9.8Cr	12Cr	16Cr
Other Receivables	1.66Cr	6.42Cr	2.87Cr	3.36Cr	1.39Cr
Notes Receivable	-	-	-	-	-
Total Receivables	6.44Cr	15Cr	13Cr	15Cr	17Cr
Inventory	1.98Cr	3.58Cr	5.67Cr	5.03Cr	5.04Cr
Prepaid Expenses	70.38L	1.41Cr	2.23Cr	71.08L	79.24L
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	9L	-	-	-	-
Total Current Assets	53Cr	121.21Cr	84Cr	109.68Cr	106.66Cr
Gross Property Plant And Equipment	5.85Cr	8.61Cr	12Cr	15Cr	16Cr
Accumulated Depreciation	-2.63Cr	-3.29Cr	-3.69Cr	-4.66Cr	-5.93Cr
Net Property Plant And Equipment	3.22Cr	5.32Cr	8.47Cr	10Cr	9.7Cr
Long-term Investments	14Cr	7.65Cr	7.38Cr	4.84Cr	8.28Cr
Goodwill	33.07L	33.8L	-	-	-
Other Intangibles, Total	2L	2L	-	-	-
Deferred Tax Assets Long-Term	15.15L	94.01L	1.54Cr	1.55Cr	1.24Cr
Deferred Charges Long-Term	11.71L	-	-	-	-
Other Long-Term Assets, Total	1.55Cr	1.8Cr	1.57Cr	1.47Cr	1.54Cr
Total Assets	72Cr	137.27Cr	102.94Cr	127.98Cr	127.42Cr
Liabilities
Accounts Payable, Total	3.16Cr	4.12Cr	7.11Cr	3.63Cr	4.25Cr
Accrued Expenses, Total	11Cr	18Cr	23Cr	23Cr	21Cr
Short-term Borrowings	4L	-	-	3.12Cr	-
Current Portion of Long-Term Debt	-	2.69Cr	-	-	2.34Cr
Current Portion of Leases	27.85L	49.17L	37.08L	39.27L	29.25L
Current Income Taxes Payable	11.2L	1.55Cr	11.12L	25.8L	15.49L
Unearned Revenue Current, Total	19.71L	1.26Cr	1.4Cr	5.85Cr	6.17Cr
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	97.63L	2.84Cr	3.72Cr	3.96Cr	3Cr
Total Current Liabilities	16Cr	31Cr	35Cr	40Cr	38Cr
Long-Term Debt	2.74Cr	-	1.81Cr	4.82Cr	5.94Cr
Long-Term Leases	60.64L	71.61L	51.96L	28.6L	40.89L
Unearned Revenue Non Current	5L	9L	-	6.95Cr	4.84Cr
Deferred Tax Liability Non Current	50.63L	27.65L	27.1L	14.84L	29.9L
Other Non Current Liabilities	77.21L	1.07Cr	1.27Cr	1.13Cr	1.08Cr
Total Liabilities	21Cr	33Cr	39Cr	54Cr	50Cr
Common Stock, Total	7.28Cr	8.65Cr	8.65Cr	8.71Cr	8.72Cr
Additional Paid In Capital	82Cr	150.52Cr	149.73Cr	152.24Cr	151.75Cr
Retained Earnings	-42Cr	-61Cr	-97Cr	-87Cr	-83Cr
Comprehensive Income and Other	44.77L	55.72L	-19.03L	-81.63L	-1.16Cr
Total Common Equity	48Cr	99Cr	61Cr	73Cr	76Cr
Minority Interest	3.48Cr	5.26Cr	2.65Cr	1.28Cr	1.19Cr
Total Equity	52Cr	103.95Cr	64Cr	74Cr	77Cr
Total Liabilities And Equity	72Cr	137.27Cr	102.94Cr	127.98Cr	127.42Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	72Cr	86Cr	85Cr	85Cr	85Cr
ECS Total Common Shares Outstanding	72Cr	86Cr	85Cr	85Cr	85Cr
Book Value / Share	0.67	1.15	0.72	0.86	0.89
Tangible Book Value	48Cr	98Cr	61Cr	73Cr	76Cr
Tangible Book Value Per Share	0.66	1.15	0.72	0.86	0.89
Total Debt	3.67Cr	3.9Cr	2.7Cr	8.61Cr	8.98Cr
Net Debt	-40Cr	-98Cr	-61Cr	-80Cr	-75Cr
Debt Equivalent Oper. Leases	2.98Cr	3.53Cr	4.3Cr	4.41Cr	3.8Cr
Minority Interest, Total (Incl. Fin. Div)	3.48Cr	5.26Cr	2.65Cr	1.28Cr	1.19Cr
Equity Method Investments, Total	14Cr	7.65Cr	7.38Cr	4.84Cr	7.78Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	45.02L	1.58Cr	2.74Cr	2.68Cr	2.43Cr
Inventories - Finished Goods, Total	1.53Cr	1.99Cr	2.93Cr	2.35Cr	2.61Cr
Buildings, Total	23.72L	24.32L	22.33L	5.67Cr	5.83Cr
Machinery, Total	2.87Cr	3.39Cr	3.92Cr	6.33Cr	6.8Cr
Full Time Employees	1.28T	1.76T	2.02T	1.99T	1.81T
Accumulated Allowance for Doubtful Accounts (Supple)	95T	20T	60T	2L	70T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-13Cr	-19Cr	-36Cr	10Cr	3.77Cr
Depreciation & Amortization - CF	59.43L	71.9L	86.64L	82.07L	1.23Cr
Amortization of Goodwill and Intangible Assets - (CF)	1L	-	-	-	-
Depreciation & Amortization, Total	60.61L	71.9L	86.64L	82.07L	1.23Cr
Amortization of Deferred Charges, Total - (CF)	43T	44T	18T	-	-
(Gain) Loss From Sale Of Asset	85T	70T	1L	-10T	10T
(Gain) Loss on Sale of Investments - (CF)	-	-12Cr	1L	-45T	-
Asset Writedown & Restructuring Costs	-	-	-	57.66L	29.15L
(Income) Loss On Equity Investments - (CF)	-7.9Cr	-6.06Cr	-4.98Cr	-4.73Cr	-4.65Cr
Stock-Based Compensation (CF)	1.96Cr	4.2Cr	3.06Cr	3.66Cr	2.16Cr
Provision and Write-off of Bad Debts	77T	-76T	43T	1L	-98T
Other Operating Activities, Total	8.75Cr	9.07Cr	4.37Cr	4.4Cr	3.46Cr
Change In Accounts Receivable	-46.93L	-3.56Cr	-1.45Cr	-2.13Cr	-3.85Cr
Change In Inventories	-36.23L	-1.6Cr	-2.12Cr	41.35L	-8L
Change In Accounts Payable	76.51L	95.65L	2.99Cr	-3.25Cr	61.94L
Change in Unearned Revenues	-2L	1.11Cr	4L	12Cr	-2.6Cr
Change in Other Net Operating Assets	3.01Cr	6.35Cr	6.4Cr	10.79L	-30.8L
Cash from Operations	-6.21Cr	-20Cr	-27Cr	22Cr	5L
Capital Expenditure	-79.49L	-1.64Cr	-3.67Cr	-3.26Cr	-1.79Cr
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-29.9L	-
Sale (Purchase) of Real Estate properties	-1.4Cr	6L	-	-	12.78L
Investment in Marketable and Equity Securities, Total	-10Cr	-28Cr	33Cr	-26Cr	-7.94Cr
Other Investing Activities, Total	-	-1.5Cr	-	-	-
Cash from Investing	-13Cr	-31Cr	30Cr	-29Cr	-9.61Cr
Long-Term Debt Issued, Total	-	-	1.78Cr	6.17Cr	3.62Cr
Total Debt Issued	-	-	1.78Cr	6.17Cr	3.62Cr
Short Term Debt Repaid, Total	-	-6L	-	-	-
Long-Term Debt Repaid, Total	-	-	-2.69Cr	-	-3.06Cr
Total Debt Repaid	-	-6L	-2.69Cr	-	-3.06Cr
Issuance of Common Stock	32Cr	72Cr	2L	50.94L	8L
Repurchase of Common Stock	-1.29Cr	-2.73Cr	-4.81Cr	-90.71L	-3.61Cr
Other Financing Activities, Total	-95.96L	-3.94Cr	-2.57Cr	-90.68L	-10L
Cash from Financing	30Cr	65Cr	-8.28Cr	4.87Cr	-3.07Cr
Foreign Exchange Rate Adjustments	55.46L	24.27L	-94.9L	-64.71L	-34.01L
Net Change in Cash	11Cr	14Cr	-6.43Cr	-2.97Cr	-13Cr
Supplemental Items
Cash Interest Paid	8L	4L	2L	4L	25.09L
Cash Income Tax Paid (Refund)	59.4L	50.14L	1.89Cr	37.28L	35.87L
Levered Free Cash Flow	-5.48Cr	-15Cr	-19Cr	3.97Cr	-5.07Cr
Unlevered Free Cash Flow	-5.43Cr	-15Cr	-19Cr	4.02Cr	-4.9Cr
Change In Net Working Capital	-5.08Cr	-1.83Cr	-6.22Cr	-1.65Cr	3.77Cr
Net Debt Issued / Repaid	-	-6L	-91.7L	6.17Cr	56.07L

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-20.67	-19.57	-21.22	0.99	-2.14
Return on Total Capital	-27.24	-25.12	-29.25	1.54	-3.23
Return On Equity %	-27.77	-21.44	-43	14.65	5.04
Return on Common Equity	-32.57	-26.46	-45.18	15.03	5.06
Margin Analysis
Gross Profit Margin %	-59.36	-56.49	-63.69	18.08	10.98
SG&A Margin	26.91	35.7	31.92	15.89	17.92
EBITDA Margin %	-83.61	-90.17	-93.58	3.17	-4.98
EBITA Margin %	-86.22	-92.19	-95.61	2.19	-6.94
EBIT Margin %	-86.27	-92.19	-95.61	2.19	-6.94
Income From Continuing Operations Margin %	-50.67	-46.9	-84.52	12.06	6.06
Net Income Margin %	-55.15	-54.66	-84.62	12.03	5.99
Net Avail. For Common Margin %	-55.15	-54.66	-84.62	12.03	5.99
Normalized Net Income Margin	-34.83	-56.27	-52.97	8.27	4.91
Levered Free Cash Flow Margin	-24.03	-43.36	-44.65	4.74	-8.05
Unlevered Free Cash Flow Margin	-23.83	-43.27	-44.56	4.79	-7.77
Asset Turnover
Asset Turnover	0.38	0.34	0.36	0.73	0.49
Fixed Assets Turnover	7.79	8.35	6.19	8.86	6.26
Receivables Turnover (Average Receivables)	5	5.42	4.7	7.8	4.63
Inventory Turnover (Average Inventory)	20.2	20.08	15.1	12.84	11.15
Short Term Liquidity
Current Ratio	3.35	3.89	2.37	2.72	2.83
Quick Ratio	3.18	3.73	2.15	2.58	2.68
Operating Cash Flow to Current Liabilities	-0.39	-0.66	-0.76	0.54	0
Days Sales Outstanding (Average Receivables)	73.15	67.36	77.71	46.8	79.11
Days Outstanding Inventory (Average Inventory)	18.12	18.18	24.17	28.43	32.84
Average Days Payable Outstanding	27.72	23.17	28.51	28.83	25.71
Cash Conversion Cycle (Average Days)	63.55	62.37	73.38	46.4	86.23
Long Term Solvency
Total Debt/Equity	7.07	3.75	4.24	11.59	11.64
Total Debt / Total Capital	6.6	3.61	4.07	10.38	10.42
LT Debt/Equity	6.46	0.69	3.66	6.87	8.23
Long-Term Debt / Total Capital	6.03	0.66	3.51	6.15	7.37
Total Liabilities / Total Assets	28.33	24.27	38.13	41.91	39.42
EBIT / Interest Expense	-249.9	-554.59	-625.3	24.21	-15.22
EBITDA / Interest Expense	-237.46	-534.99	-603.77	42.29	-9.27
(EBITDA - Capex) / Interest Expense	-247.56	-562.7	-660	-0.68	-15.51
Total Debt / EBITDA	-0.2	-0.12	-0.07	2.68	-3.37
Net Debt / EBITDA	2.15	3.08	1.54	-25.01	28.14
Total Debt / (EBITDA - Capex)	-0.19	-0.12	-0.06	-167.9	-2.02
Net Debt / (EBITDA - Capex)	2.06	2.93	1.41	1.57T	16.81
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.27	56.21	19.73	96.52	-24.8
Gross Profit, 1 Yr. Growth %	44.8	48.68	34.99	-155.8	-54.33
EBITDA, 1 Yr. Growth %	34.76	68.48	24.26	-106.66	-217.99
EBITA, 1 Yr. Growth %	34.36	66.94	24.18	-104.51	-337.85
EBIT, 1 Yr. Growth %	34.35	66.94	24.18	-104.51	-337.85
Earnings From Cont. Operations, 1 Yr. Growth %	11.42	44.6	115.75	-128.05	-62.24
Net Income, 1 Yr. Growth %	18.59	54.81	85.38	-127.93	-62.56
Normalized Net Income, 1 Yr. Growth %	21.96	152.39	12.72	-130.68	-55.39
Diluted EPS Before Extra, 1 Yr. Growth %	13.11	36.31	73.46	-127.58	-66.28
Accounts Receivable, 1 Yr. Growth %	10.67	74.6	17.24	19.29	33.06
Inventory, 1 Yr. Growth %	21.95	80.89	58.55	-11.35	0.28
Net Property, Plant and Equip., 1 Yr. Growth %	22.05	65.15	59.29	23.29	-7.09
Total Assets, 1 Yr. Growth %	55.68	89.56	-25	24.32	-0.44
Tangible Book Value, 1 Yr. Growth %	68.85	104.62	-38.15	19.69	4.02
Common Equity, 1 Yr. Growth %	68.09	103.85	-38.15	19.69	4.02
Cash From Operations, 1 Yr. Growth %	-23.29	229.04	31.52	-181.63	-99.77
Capital Expenditures, 1 Yr. Growth %	-7.19	106.33	123.55	-11.05	-45.01
Levered Free Cash Flow, 1 Yr. Growth %	-38.48	186.52	23.28	-120.75	-227.89
Unlevered Free Cash Flow, 1 Yr. Growth %	-38.68	188.31	23.28	-121.05	-221.91
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.19	31.84	36.76	53.4	21.57
Gross Profit, 2 Yr. CAGR %	75.38	46.73	41.67	-13.21	-49.52
EBITDA, 2 Yr. CAGR %	46.3	50.68	44.69	-71.23	-71.96
EBITA, 2 Yr. CAGR %	45.74	49.76	43.98	-76.34	-67.26
EBIT, 2 Yr. CAGR %	45.7	49.76	43.98	-76.34	-67.26
Earnings From Cont. Operations, 2 Yr. CAGR %	27.3	26.93	76.63	-22.21	-67.46
Net Income, 2 Yr. CAGR %	29.64	35.49	69.41	-28.04	-67.66
Normalized Net Income, 2 Yr. CAGR %	31.96	75.44	68.67	-41.19	-63.01
Diluted EPS Before Extra, 2 Yr. CAGR %	26.48	24.17	53.77	-31.12	-69.5
Accounts Receivable, 2 Yr. CAGR %	5.56	39.01	43.07	18.26	25.99
Inventory, 2 Yr. CAGR %	26.72	48.53	69.35	18.56	-5.71
Net Property, Plant and Equip., 2 Yr. CAGR %	39.18	41.97	62.19	40.14	7.03
Total Assets, 2 Yr. CAGR %	16.65	71.79	19.23	-3.44	11.25
Tangible Book Value, 2 Yr. CAGR %	11.66	85.87	12.7	-13.96	11.58
Common Equity, 2 Yr. CAGR %	11.56	85.11	12.28	-13.96	11.58
Cash From Operations, 2 Yr. CAGR %	37.46	58.87	108.03	3.62	-95.7
Capital Expenditures, 2 Yr. CAGR %	11.76	38.38	114.77	41.01	-30.06
Levered Free Cash Flow, 2 Yr. CAGR %	29.73	31.7	87.94	-49.31	-48.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.31	31.89	88.53	-48.95	-49.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.86	18.48	27.67	54.33	20.96
Gross Profit, 3 Yr. CAGR %	137.2	65.98	42.71	3.85	-29.93
EBITDA, 3 Yr. CAGR %	55.35	53.35	41.3	-48.14	-53.95
EBITA, 3 Yr. CAGR %	54.48	52.52	40.69	-54.62	-48.94
EBIT, 3 Yr. CAGR %	54.41	52.46	40.69	-54.62	-48.94
Earnings From Cont. Operations, 3 Yr. CAGR %	71.35	32.82	51.48	-4.35	-38.86
Net Income, 3 Yr. CAGR %	67.54	37.54	50.42	-7.11	-42.13
Normalized Net Income, 3 Yr. CAGR %	69.86	63.8	51.39	-4.43	-46.37
Diluted EPS Before Extra, 3 Yr. CAGR %	60.81	29.67	38.81	-13	-45.71
Accounts Receivable, 3 Yr. CAGR %	4.23	24.84	31.34	34.66	23
Inventory, 3 Yr. CAGR %	18.8	42.68	51.8	36.49	12.12
Net Property, Plant and Equip., 3 Yr. CAGR %	31.3	47.35	47.53	48.02	22.2
Total Assets, 3 Yr. CAGR %	6.59	37.15	30.32	20.9	-2.45
Tangible Book Value, 3 Yr. CAGR %	1.62	36.64	28.96	14.98	-8.34
Common Equity, 3 Yr. CAGR %	1.59	36.39	28.45	14.7	-8.34
Cash From Operations, 3 Yr. CAGR %	90.75	83.88	49.18	52.3	-86.55
Capital Expenditures, 3 Yr. CAGR %	16.56	37.1	62.37	60.09	3.02
Levered Free Cash Flow, 3 Yr. CAGR %	7.93	68.04	28.83	-9.71	-30.99
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.27	68.89	28.96	-9.09	-31.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.05	10.51	12.07	31.38	25.2
Gross Profit, 5 Yr. CAGR %	46.49	95.09	93.01	28.06	-5.83
EBITDA, 5 Yr. CAGR %	89.71	48.57	50.99	-21.48	-26.01
EBITA, 5 Yr. CAGR %	82.67	47.77	50.21	-27.63	-21.48
EBIT, 5 Yr. CAGR %	82.29	47.71	50.15	-27.64	-21.48
Earnings From Cont. Operations, 5 Yr. CAGR %	61.77	62.91	73.44	7.24	-18.11
Net Income, 5 Yr. CAGR %	29.14	75.48	68.28	6.14	-18.67
Normalized Net Income, 5 Yr. CAGR %	15.93	86.23	69.38	8.73	-13.84
Diluted EPS Before Extra, 5 Yr. CAGR %	22.98	65.82	57.95	1.04	-24.15
Accounts Receivable, 5 Yr. CAGR %	6.19	12.79	18.31	22.17	29.17
Inventory, 5 Yr. CAGR %	15.65	22.77	36.9	32.49	25.47
Net Property, Plant and Equip., 5 Yr. CAGR %	30.49	39.8	42.88	44.42	29.76
Total Assets, 5 Yr. CAGR %	25.83	32.01	11.48	19.19	22.33
Tangible Book Value, 5 Yr. CAGR %	43.33	40.34	5.91	13.64	21.7
Common Equity, 5 Yr. CAGR %	42.17	39.88	5.74	13.43	21.42
Cash From Operations, 5 Yr. CAGR %	45.91	84.44	97.48	46.18	-63.89
Capital Expenditures, 5 Yr. CAGR %	19.05	30.54	48.84	38.65	15.93
Levered Free Cash Flow, 5 Yr. CAGR %	35.86	59.15	34.31	4.04	-10.63
Unlevered Free Cash Flow, 5 Yr. CAGR %	37.58	61.11	34.73	4.65	-11.19